Managing COVID-19 at Home: A Toolbox
Helpful patient education suggestions for the successful management of COVID-19 at home and when it is appropriate to seek medical attention.
Read More
Study Finds Oral Azacitidine as AML Maintenance Treatment Prolongs Survival
February 3rd 2021Patients with AML that has gone into remission following initial chemotherapy were found to remain in remission longer and have improved OS if they took a pill form of azacitidine as a maintenance treatment.
Read More
Study Finds Many Families Hesitant to Take Children to Emergency Department During COVID-19 Pandemic
February 3rd 2021Study shows the greatest hesitancy in seeking emergency medical services among families living in under-resourced communities, which highlight health inequities that already exist during the pandemic.
Read More
Biden Administration Launches Federal Retail Pharmacy Program for COVID-19 Vaccine Administration
February 3rd 2021The participating national pharmacy partners and independent pharmacy networks represent more than 40,000 pharmacy locations and is a key component of the administration’s national strategy to expand access to vaccines.
Read More
First Mammography Screening Guidelines Issued for Older Survivors of Breast Cancer
February 2nd 2021The guidelines recommend discontinuing routine mammograms for survivors with a life expectancy under 5 years, considering stopping screening for those with a 5- to 10-year life expectancy, and continuing mammography for those whose life expectancy is greater than 10 years.
Read More
Study: Male Breast Cancer Patients Have High Prevalence of Heart Disease Risk Factors
February 1st 2021Research highlights the need for cardiologists and cardio-oncologists to be involved in the treatment of men with breast cancer due to common risk factors and potential cardiotoxic effects of treatment.
Read More
Partnerships Between Medicaid Programs and PBMs Will Shape Future of Health Care
Value-based contracts can lower costs for payers, offer pharmaceutical companies valuable feedback about their therapies, and, ultimately, improve the quality of health care.
Read More
Preprint Research on Pfizer COVID-19 Vaccine Shows Greater Efficacy Two Weeks Post Administration
February 1st 2021New data from an unreviewed, preprint research article indicate first-dose immunization efficacy of the Pfizer-BioNTech coronavirus 2019 vaccine improves by 51% 13-24 days post administration.
Read More